Comparison of Two Surgical Techniques for Open Subpectoral Biceps Tenodesis
Launched by STANFORD UNIVERSITY · Jan 21, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical techniques for a procedure called biceps tenodesis, which is done to treat problems with the biceps tendon in the shoulder. Participants who are 18 years or older and are experiencing pain or issues with their biceps tendon, possibly along with shoulder problems, may be eligible to join the study. However, those under 18 or with a history of previous injuries or surgeries to the biceps tendon will not be included.
If you decide to participate, you'll be randomly assigned to one of two groups. One group will have the standard procedure using one anchor to secure the tendon, while the other group will use two smaller anchors. Regardless of the group, both methods are safe and commonly used. After the surgery, you'll have some special imaging done to track the position of a small marker placed on the tendon at different times, including two weeks and six months after the surgery, to help the researchers understand how well each technique works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant age 18 and above who would otherwise indicated for biceps tenodesis due to biceps tendinopathy with or without associated rotator cuff pathology
- Exclusion Criteria:
- • Participant under the age of 18 will be excluded from the study as there is no indication to perform this procedure in children.
- • Any participant who had previous surgery or injury to their biceps or biceps tendon will be excluded.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Freehill, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported